Showing results (11-20 of 163) with videos related to

Sort By:
Pageof 17
Pathology, Research and Practice|July 29, 2016
The utility of SATB2 immunohistochemical expression in distinguishing between osteosarcomas and their malignant bone tumor mimickers, such as Ewing sarcomas and chondrosarcomasIsidro Machado, Samuel Navarro, Piero Picci, et al.
Human Pathology|August 7, 2009
Aberrant copy numbers of ALK gene is a frequent genetic alteration in neuroblastomasManish Mani Subramaniam, Marta Piqueras, Samuel Navarro, et al.
Histopathology|June 15, 2011
Prognostic value of partial genetic instability in neuroblastoma with ≤50% neuroblastic cell contentMarta Piqueras, Samuel Navarro, Adela Cañete, et al.
BMC Cancer|May 24, 2019
Vitronectin as a molecular player of the tumor microenvironment in neuroblastomaRebeca Burgos-Panadero, Inmaculada Noguera, Adela Cañete, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|July 25, 2007
Renal malakoplakia as a pseudotumoral lesion in a renal transplant patient: a case reportIsidro Machado Puerto, Julia Cruz Mojarrieta, Israel Borrajero Martinez, et al.
Pediatric Blood & Cancer|January 26, 2017
A stiff extracellular matrix is associated with malignancy in peripheral neuroblastic tumorsIrene Tadeo, Ana P Berbegall, Samuel Navarro, et al.
Cancer|April 4, 2003
Cytokeratin expression patterns in low-grade papillary urothelial neoplasms of the urinary bladderDavid Ramos, Samuel Navarro, Rafael Villamón, et al.
Virchows Archiv : an International Journal of Pathology|December 11, 2007
Expression of CCN3 protein in human Wilms' tumors: immunohistochemical detection of CCN3 variants using domain-specific antibodiesManish Mani Subramaniam, Noureddine Lazar, Samuel Navarro, et al.
American Journal of Clinical Pathology|January 16, 2002
CD99 immunoreactivity in atypical fibroxanthoma: a common feature of diagnostic valueCarlos Monteagudo, Luis Calduch, Samuel Navarro, et al.
Neoplasia (New York, N.Y.)|December 29, 2024
Tackling ALT-positive neuroblastoma: is it time to redefine risk classification systems? A systematic review with IPD meta-analysisMarta Avinent-Pérez, Frank Westermann, Samuel Navarro, et al.
Pageof 17